Selected representative matters handled by the principal of the firm:

Transactional:

  • Exclusive license and supply agreement with pharmaceutical partner for national brand OTC pain reliever and fever reducer drug
  • Exclusive license and supply agreement with pharmaceutical partner for national brand OTC pain reliever drug
  • Exclusive license and supply agreement with pharmaceutical partner for Rx oncology drug
  • Exclusive license and supply agreement with pharmaceutical partner for Rx BPH drugs
  • Exclusive license and supply agreement with pharmaceutical partner for Rx pain therapy drug
  • Exclusive license and supply agreement with pharmaceutical partner for branded Rx neurological drug
  • Master services agreement with branded pharmaceutical company for range of development and manufacturing services
  • License agreement with pharmaceutical company to resolve Hatch Waxman patent dispute over vitamin D analogue. Exclusive development and supply agreement for national brand chewable allergy medication
  • Exclusive development and supply agreement for national brand soft gel allergy medication.
  • Exclusive supply agreement for generic Rx prescription omega-3 product for managing triglycerides
  • Supply agreement for branded Rx prescription eicosapentaenoic acid product for managing triglycerides
  • Cross-licensing arrangement between Fortune 100 chemical companies to resolve dispute over modified polymer technology
  • Herbicide tolerant technology in and out licenses with multiple universities and commercialization partners
  • Numerous development, supply, commercialization, etc. agreements in the pharmaceuticals and nutritionals sector
  • Acquisition of US automotive parts company by Chinese manufacturer
  • Prepared template quality agreements and pharmacovigilance agreements

Intellectual Property:

  • Managed Para. IV patent challenge for generic BPH drug in collaboration with partner
  • Managed Para. IV patent challenge for oncology drug in collaboration with partner
  • Managed Para. IV patent challenge for vitamin D analogue
  • Managed Para. IV patent challenge for pain therapy drug in collaboration with partner
  • Successfully defended opposition in European Patent Office to grant of key pharmaceutical platform technology patent
  • Successfully opposed grant European Patent for fiber configuration
  • Due diligence on pesticide and biotechnology portfolio for acquirer of agricultural products business
  • Managed relationship with the Argentinian department of agriculture for licensed crop protection technology portfolio
  • Managed litigation invalidating key competitor patent in stain blocking technology
  • Negotiated intellectual property aspects of joint venture with Chinese joint venture partner building a polymer extrusion facility in China
  • Advised on Hatch-Waxman Paragraph IV notice packages
  • Advised startup pharma company regarding foundation IP agreement related to peptide therapeutics
  • Trademark portfolio management
  • Trademark searching and opinion
  • Patentability searching and opinions
  • Advised on fair use / copyright infringement for use of tunes with parody lyrics